With this approval, DYSPORT THERAPEUTIC now has the broadest label of all approved botulinum neurotoxins for spasticity, which includes both upper and lower limb spasticity in adults, as well as lower ...

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...

The FINANCIAL — Allergan plc on August 20 announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s resubmission of its Supplemental Biologics License Application (sBLA) ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

The FDA has approved Botox for the treatment of lower limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. The treatment was already approved for ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...